UK Watchdog Says UnitedHealth Takeover Of EMIS Could Hurt National Health Service
The UK competition regulator released a statement on Friday that the initial investigation into UnitedHealth’s 1.24 billion-pound acquisition of EMIS could reduce competition, leading to potentially negative outcomes for National Health Service, patients, and taxpayers.
The Competition and Markets Authority said the deal to combine the healthcare software and data specialists could lead to lower quality and more expensive software options for the NHS.
Related: DOJ To Appeal Loss In UnitedHealth-Change Merger Challenge
In particular, competition could be substantially reduced in the so-called population health management and medicines-optimization software markets, which enable the safe and effective use of medicines, the CMA said.
The takeover offer was first disclosed in June 2022, and was made by Bordeaux an affiliate of Optum Health Solutions, and subsidiary of UnitedHealth.
The CMA is concerned the deal could affect services provided by Optum’s competitors, as they rely on digital connections to the data EMIS holds, and integrations with EMIS’s electronic patient record system.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan